CONTACT | Print Page | Sign In | Join
News & Press: Other

NCATS Funding Opportunities Are Open - Prepare Your Applications

Monday, September 23, 2019   (0 Comments)
Share |

Prepare Your Applications for Upcoming NCATS Funding Opportunities

2020 Contract Topics application deadline: Oct. 23, 2019, 5:00 p.m. ET

Omnibus Solicitation application deadline: Jan. 6, 2020, 5:00 p.m. local time



TheNational Center for Advancing Translational Sciences (NCATS)has funding opportunities open for small business biotech entrepreneurs and researchers under theSmall Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.


2020 Contract Topics Solicitation: due Oct. 23, 2019


NCATS is soliciting applications for the 2020 SBIRcontract solicitation(PHS 2020-1), due Oct. 23, 2019. The topic is “Alternatives to commercially available cell culture insert membranes and manufacturing techniques (Contract Topic #019).”


Applicants are strongly encouraged to carefully read thecontract solicitationfor eligibility, detailed information about the topic and awards, as well as submission information and timelines. To submit your proposal, you must use theeCPS.No other method of proposal submission is permitted.


For questions on NCATS SBIR contract topics, please contact NCATS Contracting Officer Jeffrey Schmidt


2019 Omnibus Grant Solicitation: due Jan. 6, 2020


Small businesses and research organizations involved in commercializing innovative medical technologies are encouraged to apply for the 2019 Omnibus Grant Solicitations (SBIR:PA-19-272) andSTTR: PA-19-270). If you have your application almost ready, be sure to submit by the Jan. 6, 2020 deadline. The next deadline will be Apr. 6, 2020. NCATS is particularly interested in applications that address research areas relevant to any stage of translation, from target validation through pre-clinical and clinical evaluation, to intervention implementation and dissemination, including:


· Preclinical Drug Discovery and Development

· Biomedical, Clinical and Health Research Informatics

· Clinical, Dissemination and Implementation Research


SBIR and STTR applicants can apply forPhase I and Phase II funding. SBIR applicants can also now opt to apply forDirect-to-Phase II Funding. This award allows small businesses to submit Direct-to-Phase II SBIR applicationsif the small business has performed the Phase I stage-type research through other funding sources.An updatedSBIR/STTR Application Guidewith additional instructions for the newly reinstated SBIR Direct Phase II application preparation and submission is now available.

Questions?NCATS encourages applicants to emailNCATS-SBIRSTTR@mail.nih.govto discuss potential project ideas and related questions.


Why Apply?


· Funding is stable, predictable and not a loan

· Capital is non-dilutive

· Small businesses and research organizations retain intellectual property rights

· NIH’s rigorous peer-review provides recognition, validation and visibility to early-stage companies

· Prestige associated with these awards can help attract more funding or other support (e.g., venture capital, strategic partners)


Tips for Applying:

1. Clear all administrative requirements:Applicants must meet alleligibility requirementsand must complete all required registrations prior to submission. Register your small business,SAM.govand theNIH eRA Commonsas soon as possible. Principal Investigators must also individually register with NIH eRA Commons. Those eligible to certify as aWomen-Owned Small Business (WOSB)should obtain the WOSB designation, and those eligible to certify as aMinority-Owned Small Businessshould obtain certification.

2. Build and submit a strong application:Follow theSBIR/STTR Application Guideto ensure proper grant application content and format. You can also findexamples of successful applicationson a variety of topics on the NIH website.

3. Submit before the deadline:Completing all the required steps can take a month or two, so don’t wait until the last minute: Plan ahead to help ensure your application moves forward for consideration successfully.


Connect with us! Like us onFacebookand follow us onTwitter. Use #NCATSsbir and join the online conversation.


NCATS’ SBIR and STTR programs are engines of innovation for developing and commercializing tools, technologies and intervention platforms to support the creation of new therapeutics and diagnostics. SBIR and STTR are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 6,700 establishments and research organizations in the BioPharma, MedTech, HealthIT & BioAg that collectively employ nearly 94,000 Floridians.